Is hepatojugular reflux a good predictor of heart failure with preserved ejection fraction?

Baldivia, Guilherme Cristianini; Napoli, João Vitor Moraes Pithon; Motta, Josiane Motta E; Filho, Normando Gomes Vieira; Lopes, Heno Ferreira

doi:10.1590/1806-9282.65.5.592

Cited by 1 publication

(3 citation statements)

References 9 publications

(5 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A recent study suggests that HJR has value as a prognostic marker for post‐discharge outcomes in hospitalized patients with heart failure 36 . Another study also supports the clinical significance of HJR in that it may help assess heart failure with preserved ejection fractions 37 . Our results support the usefulness of positive HJR for confirming CHF without relying on imaging studies.…”

Section: Discussionsupporting

confidence: 82%

Section: Discussionsupporting

confidence: 80%

“… 36 Another study also supports the clinical significance of HJR in that it may help assess heart failure with preserved ejection fractions. 37 Our results support the usefulness of positive HJR for confirming CHF without relying on imaging studies. HJR therefore has potential applications in a diverse range of clinical settings, where it may help reduce health expenditures while maintaining a high standard of care.…”

Section: Discussionsupporting

confidence: 80%

See 2 more Smart Citations

The clinical value of hepatojugular reflux on congestive heart failure: A meta‐analysis

Iwata

Miwa

Ikehara

et al. 2022

J of Gen and Family Med

View full text Add to dashboard Cite

Background: Hepatojugular reflux is a cardiac physical examination with a long history of use in heart failure diagnosis across many clinical settings. However, the development of new diagnostic methods has thrown the clinical role of hepatojugular reflux into question. Our meta-analysis aimed to determine the diagnostic accuracy of hepatojugular reflux and assess its usefulness in diagnosing congestive heart failure among at-risk patients.Methods: This meta-analysis of studies reporting diagnostic hepatojugular reflux values of patients at risk for congestive heart failure followed PRISMA guidelines.We searched MEDLINE, EMBASE, Web of Science, CENTRAL, and Google Scholar for eligible studies from inception through February 1, 2021. After QUADAS-2 quality assessment, we conducted data synthesis using the random effects model and a hierarchical summary receiver operating characteristic model. As an additional analysis, we sorted the studies by clinical setting and performed synthesis again.We submitted our protocol to PROSPERO (International Prospective Register of Systematic Reviews; ID No. CRD42020215004). Results:The literature search provided 4121 studies for evaluation. Seven studies and their 5195 participants were deemed eligible for synthesis. Clinical diagnosis was the most frequent reference standard. Bivariate random-effects analysis found hepatojugular reflux sensitivity of 0.12, 95% confidence interval (CI) [0.07-0.19], and specificity of 0.96, 95% CI [0.95-0.97]. The DOR was 29.7, 95% ]. The additional analysis of the emergency settings provided a sensitivity of 0.14, 95% CI [0.12-0.17] and specificity of 0.95, 95% CI [0.93-0.96]. Conclusions:Our meta-analysis suggests that hepatojugular reflux has practical value for diagnosis of congestive heart failure with high specificity.

show abstract

Section: Discussionsupporting

confidence: 82%

Section: Discussionsupporting

confidence: 80%